Immunotherapy in Triple-Negative Breast Cancer: Present and Future

被引:0
作者
Isaac Kim
Katherine Sanchez
Heather L. McArthur
David Page
机构
[1] Providence Cancer Institute,Earle A. Chiles Research Institute
[2] Cedars-Sinai Medical Center,undefined
来源
Current Breast Cancer Reports | 2019年 / 11卷
关键词
Breast cancer; Immunotherapy; Triple-negative; Immune checkpoint blockade; PD-L1; IMpassion130;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:259 / 271
页数:12
相关论文
共 830 条
[81]  
Morris LGT(2016)Biomarkers for immunotherapy: current developments and challenges American Society of Clinical Oncology Educational Book 36 e493-undefined
[82]  
Goodman Aaron M.(2018)Clinicopathological correlation of PD-L1 expression in primary and metastatic breast cancer and infiltrating immune cells Hum Pathol 80 170-undefined
[83]  
Kato Shumei(2019)Frequent discordance in PD-1 and PD-L1 expression between primary breast tumors and their matched distant metastases Clinical & Experimental Metastasis 36 29-undefined
[84]  
Bazhenova Lyudmila(2017)New insights into the role of EMT in tumor immune escape Mol Oncol 11 824-undefined
[85]  
Patel Sandip P.(undefined)undefined undefined undefined undefined-undefined
[86]  
Frampton Garrett M.(undefined)undefined undefined undefined undefined-undefined
[87]  
Miller Vincent(undefined)undefined undefined undefined undefined-undefined
[88]  
Stephens Philip J.(undefined)undefined undefined undefined undefined-undefined
[89]  
Daniels Gregory A.(undefined)undefined undefined undefined undefined-undefined
[90]  
Kurzrock Razelle(undefined)undefined undefined undefined undefined-undefined